Your browser doesn't support javascript.
loading
A systematic safety pipeline for selection of T-cell receptors to enter clinical use.
Foldvari, Zsofia; Knetter, Cathrine; Yang, Weiwen; Gjerdingen, Thea Johanne; Bollineni, Ravi Chand; Tran, Trung The; Lund-Johansen, Fridtjof; Kolstad, Arne; Drousch, Kimberley; Klopfleisch, Robert; Leisegang, Matthias; Olweus, Johanna.
Affiliation
  • Foldvari Z; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.
  • Knetter C; Precision Immunotherapy Alliance, University of Oslo, Oslo, Norway.
  • Yang W; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.
  • Gjerdingen TJ; Precision Immunotherapy Alliance, University of Oslo, Oslo, Norway.
  • Bollineni RC; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.
  • Tran TT; Precision Immunotherapy Alliance, University of Oslo, Oslo, Norway.
  • Lund-Johansen F; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.
  • Kolstad A; Precision Immunotherapy Alliance, University of Oslo, Oslo, Norway.
  • Drousch K; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.
  • Klopfleisch R; Precision Immunotherapy Alliance, University of Oslo, Oslo, Norway.
  • Leisegang M; Precision Immunotherapy Alliance, University of Oslo, Oslo, Norway.
  • Olweus J; Department of Immunology, University of Oslo and Oslo University Hospital, Oslo, Norway.
NPJ Vaccines ; 8(1): 126, 2023 Aug 22.
Article in En | MEDLINE | ID: mdl-37607971
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: NPJ Vaccines Year: 2023 Type: Article Affiliation country: Norway
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: NPJ Vaccines Year: 2023 Type: Article Affiliation country: Norway